[The pros and cons of luminal teatment of hyperbilirubinemia].
D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors; D000818:Animals; D001663:Bilirubin / Q000097:blood / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects; D002784:Cholesterol / Q000096:biosynthesis; D003875:Drug Eruptions; D004790:Enzyme Induction; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000188:drug therapy*; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects; D051379:Mice; D010634:Phenobarbital / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012709:Serum Albumin / Q000378:metabolism; D013256:Steroids / Q000378:metabolism; D013974:Thyroxine / Q000378:metabolism
D012709:Serum Albumin; D013256:Steroids; D000324:Adrenocorticotropic Hormone; D002784:Cholesterol; D013974:Thyroxine; D001663:Bilirubin; D010634:Phenobarbital
Das Für und Wider der Luminalbehandlung von Hyperbilirubinämien.